AIIMS Delhi Begins Covaxin Covid Vaccine Trials For Children
AIIMS Delhi will begin screening children aged 2 to 18 years for Covaxin clinical trials.
If the clinical trials are successful, India will join the list of countries like the US, China, Germany and others that have approved vaccination for children.
AIIMS Delhi will begin screening children aged 2 to 18 years for Covaxin clinical trials.
If the clinical trials are successful, India will join the list of countries like the US, China, Germany and others that have approved vaccination for children.
